Matches in Wikidata for { <http://www.wikidata.org/entity/Q89719765> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q89719765 description "2018 թվականին հրատարակված գիտական հոդված" @default.
- Q89719765 description "article scientifique (publié 2018)" @default.
- Q89719765 description "articolo scientifico (pubblicato il 2018)" @default.
- Q89719765 description "artigo científico (publicado na 2018)" @default.
- Q89719765 description "artikull shkencor i botuar më 01 janar 2018" @default.
- Q89719765 description "artículo científico publicado en 2018" @default.
- Q89719765 description "artículu científicu espublizáu en xineru de 2018" @default.
- Q89719765 description "im Jahr 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q89719765 description "scientific article published on 01 January 2018" @default.
- Q89719765 description "wetenschappelijk artikel" @default.
- Q89719765 description "наукова стаття, опублікована 1 січня 2018" @default.
- Q89719765 description "научна статия" @default.
- Q89719765 name "Letter in response to "Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial" by Sarkar" @default.
- Q89719765 name "Letter in response to "Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial" by Sarkar" @default.
- Q89719765 name "Letter in response to "Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial" by Sarkar" @default.
- Q89719765 type Item @default.
- Q89719765 label "Letter in response to "Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial" by Sarkar" @default.
- Q89719765 label "Letter in response to "Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial" by Sarkar" @default.
- Q89719765 label "Letter in response to "Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial" by Sarkar" @default.
- Q89719765 prefLabel "Letter in response to "Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial" by Sarkar" @default.
- Q89719765 prefLabel "Letter in response to "Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial" by Sarkar" @default.
- Q89719765 prefLabel "Letter in response to "Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial" by Sarkar" @default.
- Q89719765 P1433 Q89719765-3D1F8AFF-9D21-4BDA-9C69-226BC6F7DE38 @default.
- Q89719765 P1476 Q89719765-63EBC5A0-5BB4-4CD4-997A-CD6632A3EC45 @default.
- Q89719765 P2093 Q89719765-BCC38313-081C-4E4D-9C69-3ADF3C79124A @default.
- Q89719765 P2093 Q89719765-E545EA5B-50E9-4D55-847D-B237166CCB6F @default.
- Q89719765 P304 Q89719765-74D8772C-A48B-43B6-9FC3-41EC6C6D43EB @default.
- Q89719765 P31 Q89719765-BCE911BE-9062-423A-B806-99EF2B80366F @default.
- Q89719765 P356 Q89719765-D0D68BF6-7BE6-4BD7-8115-D47FD27447C7 @default.
- Q89719765 P433 Q89719765-670ACCF1-63ED-4C90-9E8A-FA90AB9EA976 @default.
- Q89719765 P478 Q89719765-BCAB3CC0-070F-4F54-9E91-A621D80943E6 @default.
- Q89719765 P577 Q89719765-FD9A1F89-9CEC-4D83-9CD5-981BF5581FA1 @default.
- Q89719765 P698 Q89719765-AFBB43F7-FA17-4AC3-93C5-A74A0FCD855E @default.
- Q89719765 P921 Q89719765-4D10555D-4724-41C7-BE82-8197467BABE5 @default.
- Q89719765 P921 Q89719765-FCB8A059-0105-498D-8326-B20D43DD689B @default.
- Q89719765 P356 IJDVL.IJDVL_860_17 @default.
- Q89719765 P698 29271368 @default.
- Q89719765 P1433 Q6020774 @default.
- Q89719765 P1476 "Letter in response to "Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial" by Sarkar et al" @default.
- Q89719765 P2093 "Hywel C Williams" @default.
- Q89719765 P2093 "Nadine Marrouche" @default.
- Q89719765 P304 "59-60" @default.
- Q89719765 P31 Q13442814 @default.
- Q89719765 P356 "10.4103/IJDVL.IJDVL_860_17" @default.
- Q89719765 P433 "1" @default.
- Q89719765 P478 "84" @default.
- Q89719765 P577 "2018-01-01T00:00:00Z" @default.
- Q89719765 P698 "29271368" @default.
- Q89719765 P921 Q187440 @default.
- Q89719765 P921 Q3886240 @default.